The Prevalence and Clinical Features of Tuberculous Peritonitis in CAPD Patients in Turkey, Report of Ten Cases from Multi-centers

Figures & data

Table 1. Characteristics of the patients with TBP undergoing CAPD

Patient no.	Age/sex	Cause of renal failure	Duration of treatment of CAPD (months)	Predisposing medical conditions	Fever	Abdominal pain
1	42/F	Unknown	19	−	−	+
2	20/M	Membranous glomerulonephritis	5	Chronic hepatitis	−	+
3	31/M	Hypertension	12	−	−	+
4	49/M	Diabetic nephropathy	29	Diabetes mellitus	−	+
5	45/F	Hypertension	7	−	+	+
6	49/M	Diabetic nephropathy	9	Diabetes mellitus	−	+
7	36/F	Chronic glomerulonephritis	2	−	+	+
8	25/F	Membrano- proliferative glomerulonephritis	3	Recent immuno suppression, chronic hepatitis	+	+
9	45/M	Hypertension	6	−	+	+
10	30/F	Chronic glomerulonephritis	40	−	+	+

Table 2. Clinical and peritoneal fluids characteristics in the patients with TBP

	Clinical features				Peritoneal-fluid characteristics
Patients no.	Cloudy fluid	Coincident bacterial peritonitis	Extra- peritoneal involvement	Radiological evidence	WBC/mm^3	Poly%	Lym	Mono	Eus
1	+	−	−	−	3200		Predominantly		Lym
2	+	−	−	−	1800		Predominantly		Lym
3	+	−	−	+	4100		Predominantly		Lym
4	+	+	−	−	500	80	−
5	+	−	−	−	1100	18	82
6	+	−	−	−	5000	90	−
7	+	−	−	−	−	70	30
8	+	−	Pulmonary liver tb	+	2200	80	20
9	+	−	−	−	400	84	16
10	+	−	−	−	300	−

Poly: Polymorphs. Lym: Lymphocytes. Mono: Monocytes. Eos: Eosinophils.

Table 3. The diagnostic methods, duration to diagnosis, treatment, and short-term outcome of the patients

		Apparent onset to diagnosis		Short-term outcome catheter
Patient no.	Diagnostic method(s)	(Months)	Treatment	Removal	Dialysis	Mortality
1	Smear	1	I, R, M	+	HD	Alive
2	Smear	4	I, R, M	+	HD	R
3	Smear	8	I, R, M	+	HD	Alive
4	Smear-culture	1.5	I, R, M, E	−	CAPD	NR
5	Smear-culture	1.5	I, R, P, E	−	CAPD	Alive
6	Culture	1.5	I, R, M, E	+	HD	R
7	Culture	−	I, R, M, C	−	CAPD	Alive
8	Smear+culture+ biopsy	2	I, R, E, C	+	HD	R
9	Smear	5	I, R, E, P	+	HD	Alive
10	Culture + biopsy	−	I, R, P	+	HD	Alive

Is, Isoniazid; P, Pyrazinamide; HD, Hemodialysis.

R, Rifampicin; E, Ethambutol; CAPD, Continuous Ambulatory Peritoneal Dialysis.

M, Morphazinamide; C, Ciprofloxacin; R, related TBP; NR, Non related TBP.

Table 4. Peritonitis attacks, medical treatment, and serum albumin levels of the patients

Patient no.	Peritonitis attacks	Medical treatment before TBP diagnosis	T.protein/albumin (g/L)
1	−	V, A, M	64/31
2	1	V, A, M, F	88/38
3	6	V, A, M	60/33
4	−	V, G	57/26
5	−	C, A, V	83/49
6	−	C, A	53/19
7	−	V, A	?
8	−	?	59/25
9	−	V, A, T	58/27
10	3	?	?

V, Vancomycin; C, Cefazolin; A, Amikacin; F, Fluconazole; M, Cefepime; G, Gentamicin.